GlassScriptPhysician profile
Krystle Chua
NPI 1366882474
$6,038.98
in general payments reported to CMS, 2019-2025
39 companies · $930 in 2025
The $930 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $585 · 2021: $1,456 · 2022: $795 · 2023: $1,137 · 2024: $717 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,783.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,236.86 | 2019-2025 | Creon, Vraylar, Linzess |
| Teva Pharmaceuticals USA, INC. | $1,197.91 | 2020-2025 | Austedo Xr, Austedo Xr, Austedo |
| Novo Nordisk INC | $809.13 | 2019-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $478.65 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $245.36 | 2019-2025 | Evenity, Prolia, Otezla |
| Otsuka America Pharmaceutical, INC. | $205.04 | 2020-2025 | Rexulti, Abilify Maintena |
| Sunovion Pharmaceuticals INC. | $147.19 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $138.31 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $125.10 | 2019-2023 | |
| Exact Sciences Corporation | $121.89 | 2024-2025 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $94.12 | 2020-2024 | |
| Dexcom, INC. | $93.79 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $92.45 | 2023-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $84.53 | 2020-2025 | Spravato |
| Medtronic, INC. | $80.11 | 2021-2025 | Minimed 780g |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystle Chua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.